亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of Long-Term Outcomes between Curative and Non-Curative Resection after Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma

医学 内镜黏膜下剥离术 食管鳞状细胞癌 切除术 外科 基底细胞 癌 粘膜切除术 放射科 解剖(医学) 食道疾病 外科切除术 梅德林 食管 内镜治疗 回顾性队列研究 治疗
作者
Minkyu Choi,Byeong Yun Ahn,Quanxin Zheng,S. I. CHO,Sang Gyun Kim,Hyunsoo CHUNG
出处
期刊:Gut and Liver [Korean Association for the Study of the Liver]
标识
DOI:10.5009/gnl250377
摘要

Background/Aims: Given the limited data on the long-term outcomes of non-curative resection (non-CR) following endoscopic submucosal dissection (ESD) for patients with superficial esophageal squamous cell carcinoma (SESCC), we compared the clinical outcomes of patients who did and did not achieve curative resection (CR). Methods: This retrospective, single-center study reviewed data of patients with SESCC who underwent ESD at a tertiary referral center in Korea between 2011 and 2021. Non-CR was defined as the presence of any of the following: lymphovascular invasion, submucosal invasion, or positive vertical resection margin on ESD. Clinical outcomes and tumor-related characteristics were assessed. Results: Most patients (93.3%, 28/30) in the non-CR group underwent additional treatment, including 11 who underwent surgery and 17 who received radiotherapy, whereas no patients in the CR group required additional surgery or radiotherapy. During a median follow-up of 58 months, the cumulative rate of recurrence was 0.9% (1/108) in the CR group and 16.7% (5/30) in the non-CR group. The 5-year overall survival rate was higher in the CR group, although the between-group difference was not statistically significant (91.1% vs 82.3%, p=0.873). The 5-year recurrence-free survival rates were 98.7% and 83.2% for the CR and non-CR groups, respectively (p<0.001). The overall adverse event rates were similar between the two groups (16.7% vs 20.0%, p=0.878). Conclusions: ESD followed by appropriate treatment can yield acceptable long-term outcomes, even when CR is not achieved. These findings suggest that ESD may be a viable first-line treatment strategy for SESCC, even in patients who are unlikely to achieve CR, particularly high-risk surgical patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被xiaoping采纳,获得10
1秒前
crystal关注了科研通微信公众号
4秒前
霸气糜完成签到,获得积分10
5秒前
七七四十九完成签到 ,获得积分10
6秒前
霸气的似狮完成签到,获得积分10
10秒前
隔壁小孩完成签到,获得积分10
10秒前
11秒前
开朗的友瑶完成签到,获得积分10
17秒前
ppp发布了新的文献求助10
24秒前
阿柠发布了新的文献求助20
30秒前
31秒前
32秒前
云弦完成签到,获得积分10
32秒前
蓝懒懒完成签到 ,获得积分10
39秒前
阿柠完成签到,获得积分10
45秒前
47秒前
51秒前
拉拉裤完成签到,获得积分10
53秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
53秒前
深情安青的应助被科研通管家采纳,获得10
53秒前
Maestro_S的应助被科研通管家采纳,获得10
53秒前
慕青的应助被科研通管家采纳,获得30
53秒前
369ninja的应助被科研通管家采纳,获得10
54秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
54秒前
55秒前
56秒前
fairytaler完成签到,获得积分10
56秒前
1分钟前
1分钟前
科研通AI6.2的应助被lhw采纳,获得10
1分钟前
云弦发布了新的文献求助10
1分钟前
温暖的雪萍完成签到,获得积分10
1分钟前
ppp发布了新的文献求助10
1分钟前
1分钟前
淡然的代灵完成签到,获得积分10
1分钟前
1分钟前
1分钟前
lhw发布了新的文献求助10
1分钟前
xiaoguoxiaoguo完成签到,获得积分10
1分钟前
ycq发布了新的文献求助30
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165939
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749898
捐赠科研通 7756692
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553385
邀请新用户注册赠送积分活动 2473623